These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37406046)

  • 1. Transmission of Carbapenem-Resistant Enterobacterales in an Overcrowded Emergency Department: Controlling the Spread to the Hospital.
    Salomão MC; Freire MP; Lázari CS; Cury AP; Rossi F; Segurado AAC; Costa SF; Levin AS; Boszczowski Í;
    Clin Infect Dis; 2023 Jul; 77(Suppl 1):S46-S52. PubMed ID: 37406046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
    Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M
    Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Risk Factors of Carbapenem-resistant
    Kang JS; Yi J; Ko MK; Lee SO; Lee JE; Kim KH
    J Korean Med Sci; 2019 May; 34(18):e140. PubMed ID: 31074254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Risk for Carbapenem-Resistant Enterobacteriaceae Colonization in Intensive Care Units after Hospitalization in Emergency Department.
    Salomão MC; Freire MP; Boszczowski I; Raymundo SF; Guedes AR; Levin AS
    Emerg Infect Dis; 2020 Jun; 26(6):1156-1163. PubMed ID: 32267827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics of carbapenem-resistant
    Sun Y; Zheng H; Zhang JL; Yu LX; Wang B; Gao W; Cai JZ; Liu YH
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):640-645. PubMed ID: 32842384
    [No Abstract]   [Full Text] [Related]  

  • 6. Investigation on the transmission rate of carbapenemase-producing carbapenem-resistant Enterobacterales among exposed persons in a tertiary hospital using whole-genome sequencing.
    Chang E; Chang HE; Shin IS; Oh YR; Kang CK; Choe PG; Park WB; Choi EH; Oh MD; Park KU; Kim NJ
    J Hosp Infect; 2022 Jun; 124():1-8. PubMed ID: 35307505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast and expensive (PCR) or cheap and slow (culture)? A mathematical modelling study to explore screening for carbapenem resistance in UK hospitals.
    Knight GM; Dyakova E; Mookerjee S; Davies F; Brannigan ET; Otter JA; Holmes AH
    BMC Med; 2018 Aug; 16(1):141. PubMed ID: 30111322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Insights Into the Mechanism of Carbapenem Resistance Dissemination in Enterobacterales From a Tertiary Public Heath Setting in South Asia.
    Farzana R; Jones LS; Rahman MA; Sands K; van Tonder AJ; Portal E; Criollo JM; Parkhill J; Guest MF; Watkins WJ; Pervin M; Boostrom I; Hassan B; Mathias J; Kalam MA; Walsh TR
    Clin Infect Dis; 2023 Jan; 76(1):119-133. PubMed ID: 35412593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
    Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbapenem-resistant Enterobacteriaceae in patients admitted to the emergency department: prevalence, risk factors, and acquisition rate.
    Salomão MC; Guimarães T; Duailibi DF; Perondi MBM; Letaif LSH; Montal AC; Rossi F; Cury AP; Duarte AJS; Levin AS; Boszczowski I
    J Hosp Infect; 2017 Nov; 97(3):241-246. PubMed ID: 28826688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for in-hospital acquisition of carbapenem-resistant Enterobacterales in patients with severe burns.
    Han SB; Jeon K; Kim M; Park J; Yoon J; Cho YS; Hur J; Chun W; Kym D
    J Hosp Infect; 2024 Jul; 149():165-171. PubMed ID: 38740304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance and burden of carbapenem-resistant Enterobacterales (CRE) colonization acquisition in hospitalized patients.
    Hassoun-Kheir N; Hussien K; Karram M; Saffuri M; Badaan S; Peleg S; Aboelhega W; Warman S; Alon T; Pollak D; Szwarcwort Cohen M; Paul M
    Antimicrob Resist Infect Control; 2023 Nov; 12(1):129. PubMed ID: 37986092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of the Xpert Carba-R™ assay directly from rectal swabs for active surveillance of carbapenemase-producing organisms in the largest Brazilian University Hospital.
    Cury AP; Almeida Junior JN; Costa SF; Salomão MC; Boszczowski Í; Duarte AJS; Rossi F
    J Microbiol Methods; 2020 Apr; 171():105884. PubMed ID: 32142746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter study on the prevalence of colonization due to carbapenem-resistant
    Fasciana T; Antonelli A; Bianco G; Lombardo D; Codda G; Roscetto E; Perez M; Lipari D; Arrigo I; Galia E; Tricoli MR; Calvo M; Niccolai C; Morecchiato F; Errico G; Stefani S; Cavallo R; Marchese A; Catania MR; Ambretti S; Rossolini GM; Pantosti A; Palamara AT; Sabbatucci M; Serra N; Giammanco A
    Front Public Health; 2023; 11():1270924. PubMed ID: 38186699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbapenem-resistant Enterobacteriaceae among kidney transplant recipients - insights on the risk of acquisition and CRE infection.
    Freire MP; Carvalho LB; Reusing JO; Spadão F; Lopes MIBF; Nahas WC; David-Neto E; Pierrotti LC
    Infect Dis (Lond); 2021 Jun; 53(6):430-439. PubMed ID: 33612056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, risk factors, and prediction score of carbapenem resistance among inpatients colonized or infected with 3rd generation cephalosporin resistant Enterobacterales.
    Moghnieh R; Abdallah D; Jadayel M; Zorkot W; El Masri H; Dib MJ; Omar T; Sinno L; Lakkis R; Jisr T
    Sci Rep; 2021 Jul; 11(1):14757. PubMed ID: 34285312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological Characteristics of Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae Colonization.
    Jeong IS; Song JY
    Asian Nurs Res (Korean Soc Nurs Sci); 2022 Aug; 16(3):134-139. PubMed ID: 35605957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of and risk factors for carbapenem-resistant
    Barber KE; Wagner JL; Larry RC; Stover KR
    J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33263511
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk factors and molecular epidemiology of fecal carriage of carbapenem resistant Enterobacteriaceae in patients with liver disease.
    Tian F; Li Y; Wang Y; Yu B; Song J; Ning Q; Jian C; Ni M
    Ann Clin Microbiol Antimicrob; 2023 Jan; 22(1):10. PubMed ID: 36710337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular characteristics and risk factors for patients acquiring carbapenemase-producing and non-carbapenemase-producing carbapenem-nonsusceptible-Enterobacterales bacteremia.
    Wu AY; Chang H; Wang NY; Sun FJ; Liu CP
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 2):1229-1238. PubMed ID: 34824020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.